Health - Google News: Astex Pharma ends development of lung cancer drug - Reuters

Health - Google News Google News

Astex Pharma ends development of lung cancer drug - Reuters Sep 21st 2012, 13:06 Astex Pharma ends development of lung cancer drug Reuters (Reuters) - Cancer drugmaker Astex Pharmaceuticals Inc said it would discontinue the development of its experimental small-cell lung cancer drug, Amuvatinib, as the drug failed to achieve a high enough response rate in patients in a mid-stage study. Astex ends development Amuvatinib cancer inhibitorMarketWatch Astex Pharma (ASTX) Drops After Discontinuing DNA Repair Inhibitor Amuvatinib ...iStockAnalyst Astex Pulls Plug on Phase II Anticancer DrugGenetic Engineering News NASDAQ -PharmaLive (press release) (subscription) all 26 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: